Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Download references

Open Access Highly Accessed

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

Marie Hudson*, Janet Pope, Michael Mahler, Solène Tatibouet, Russell Steele, Murray Baron, Canadian Scleroderma Research Group (CSRG) and Marvin J Fritzler

Arthritis Research & Therapy 2012, 14:R50  doi:10.1186/ar3763

Include


Format